MY FACE. MY LIFE. MAILI.

Women's Attitudes Towards Judgement, Power, and Injectable Dermal Filler Treatments

Model is an actual patient, individual results may vary.

We surveyed over 10,000
women who live in urban/suburban areas, to expose
women's attitudes towards judgement, power and dermal fillers.

Research designed by MaiLi and conducted by Censuswide,
here's what we learned from our unique global study.

87% of women

Believe face judgement for how they look.

Read the full report

Appetiser Maili Real Power Campaign (1)

88% of women

Believe should be free from social judgement.

Download our study

Emilie Real Power Campaign

61% of women

Have received abuse or negative comments in person, or online.

Read the full report

Maili Patient Happy Results

DISCOVER WHAT ELSE WE LEARNED FROM OUR GLOBAL STUDY.

Download our study

*Sinclair Pharma: ‘Women's Attitudes Towards Judgement, Power, and Injectable Dermal Filler Treatments’, December 2022. The data was collected between 09.12.2022 – 15.12.2022.

The research was conducted by Censuswide, among a sample of 10,084 18+ women who live in urban/suburban areas in the UK, Germany, Spain, Mexico, Saudi Arabia & UAE.

Indication:

CE 2797: MaiLi devices are intended for the correction of facial wrinkles or folds, for the definition or enhancement of the lips, and for the restoration or enhancement of facial volume. MaiLi is also indicated for scar tissue treatment and volume lost by HIV-associated lipoatrophy.

Indication:

CE 2797: MaiLi devices are intended for the correction of facial wrinkles or folds, for the definition or enhancement of the lips, and for the restoration or enhancement of facial volume. MaiLi is also indicated for scar tissue treatment and volume lost by HIV-associated lipoatrophy

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising. For a full list consult Instructions for Use.

The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised MaiLi distributor. Alternatively send the details to Sinclair on: quality@sinclair.com

For a full list of contraindications, warnings and precautions for this product please refer to the Product Instructions for Use.